Navigation Links
Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial
Date:12/9/2008

ith a statistically significant improvement in agitation at 10 minutes post-dose, which was sustained through the 24-hour study period. In all of the reported clinical trials to date, AZ-004 has been shown to be safe and generally well tolerated in patients and subjects.

About Symphony Allegro

In December 2006, Alexza entered into a collaboration with Symphony Capital LLC, a biotech-focused private equity firm. Under the terms of the agreement, Alexza and Symphony Capital established Symphony Allegro, Inc., which is providing funding to Alexza to accelerate clinical and other related development activities of Staccato loxapine (AZ-004 and AZ-104) and Staccato alprazolam (AZ-002). Alexza has granted a license to certain intellectual property rights for the selected product candidates. Through a purchase option, Alexza retains the exclusive right, but not the obligation, to acquire 100% of the equity of Symphony Allegro at specified prices during the term of the agreement. If Alexza chooses not to exercise the purchase option, Symphony Allegro retains the rights to the product candidates. The purchase option expires December 1, 2010.

About Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato(R) system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.

Alexza has five product candidates in clinical development. Alexza's lead program, AZ-004 (Staccato loxapine) for
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Alexzas AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
2. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
3. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
4. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
5. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
8. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
9. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
10. TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia
11. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... BioCorRx, Inc. ( BICX ... is a healthcare solutions organization, which focuses solely on ... billion in the U.S. alone. The Company created a unique ... a specially compounded form for outpatient surgical implantation. The Company ... New Zealand ) to the specially formulated ...
(Date:3/27/2015)... March 27, 2015 Across the global healthcare ... challenges in clinical development, market education, and regulatory compliance. ... Medical Affairs function is expected to increase in prominence ... According to research by benchmarking firm, Best ... group dedicated to Medical Affairs. Among companies in ...
(Date:3/27/2015)... , March 27, 2015  The quality function ... description: ensure products meet quality standards at every stage ... escalating regulations, quality leaders also have the challenge of ... Those who don,t effectively balance these priorities ... well as marketplace failure and regulatory scrutiny. ...
Breaking Medicine Technology:Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S. 2Medical Affairs Capabilities Expanding in Emerging Marketplaces 2New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2
... that a new market research report is available in ... 2016 - The Digital X-Ray Systems Segment to be ... X-Ray Systems Market to 2016 - The ... SummaryGBI Research,s new report, "X-Ray Systems ...
... 2011 The Mobile Dog Heart Health Tour is heading to ... the St. Johns Town Center from 11 a.m. to 3 ... on-site heart screenings in a soundproof medical unit, as well ... (Photo: http://photos.prnewswire.com/prnh/20110127/CG37742 ) Since early 2009, veterinarians ...
Cached Medicine Technology:Reportlinker Adds X-Ray Systems Market to 2016 - The Digital X-Ray Systems Segment to be the Growth Driver 2Free Dog Heart Checks in Jacksonville 2Free Dog Heart Checks in Jacksonville 3
(Date:3/28/2015)... FL (PRWEB) March 28, 2015 ... conditions coverage is made available to all visitors who ... effective immediately. All members are encouraged to purchase the ... to avoid lack of proper coverage for pre-existing medical ... from one or two medical conditions with serious consequences ...
(Date:3/28/2015)... 2015 An article in Fortune on ... prove critical to organizations that deal with PCI (Payment ... of data security, is worsening . Using numbers ... every major category out of the twelve measured improved, ... all the craziness that has gone on in the ...
(Date:3/28/2015)... Centurion Service Group will be hosting a live ... at their Las Vegas warehouse, located at 4606 Andrews St. ... consists of equipment from hospitals and surgery centers from around ... , Buyers will find items of all types including ... one-stop-shop,” said Erik Tivin, CEO of Centurion. , Among the ...
(Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... correlate with a history of shoulder and elbow injuries, according ... for Sports Medicine’s ( AOSSM ) Specialty Day. , “Our ... associated with a 20% increase in likelihood of a history ... is associated with a 12% increase likelihood of a history ...
(Date:3/28/2015)... 28, 2015 One in three young ... research presented today at the American Orthopaedic Society for ... examined the long term success of surgery for patients ... survey data from 242 patients who underwent ACL reconstruction ... Roe, MBBS, FRACS, from North Sydney Orthopaedic and Sports ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2
... avian virus that have infected human hosts has revealed key ... ,The research has been reported in the Nov. ... changes required for the H5N1 avian influenza virus that makes ... ,Yoshihiro Kawaoka, the senior author of the Nature ...
... symptoms like forgetting, distracted, impulsive or fidgety - ... Center// investigates whether these symptoms of Attention Deficit Hyperactivity ... ,If that is the case, will treatment for ... quit smoking – the patch with counseling – increase ...
... by the State government that legal notices have been ... of Maharashtra. ,Following a case of negligence, public ... a Govandi resident, Mariappa Gangau. His pregnant wife had ... an unqualified bogus doctor. ,The report was presented ...
... in North Korea is threatening to become an epidemic despite ... ,The infectious disease has quickly spread for almost a ... from the affected areas, the Yonhap News agency reported Wednesday, ... ,There are no apparent signs that the number of ...
... hard chocó fans could crack open a bar of chocolate, ... true colors and bares// its heart! When you melt to ... new finding. ,Researchers in the United States, ... 18-month study to gauge the influence of aspirin on blood ...
... reprieve to the many sufferers of osteoporosis, as well ... exploring the influence of dietary// supplements on osteoporosis. Scientists ... and above) to analyze the effects of vitamins on ... there is an additional risk factor for osteoporosis, which ...
Cached Medicine News:Health News:Scinetists Alert to Onset of Pandemic through Bird flu Mutations to Humans 2Health News:A New Study To Examine ADHD's Role In Smoking 2
... Rapid diagnosis of influenza A ... important due to the availability ... diagnosis of influenza using Clearview ... can lead to reduced hospital ...
... The OcuLight OR (532 nm) is ... product,family. The OcuLight family is widely,accepted ... and portability and it makes,up the ... lasers. ,The OcuLight OR laser was ...
...
...
Medicine Products: